Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: a post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS).
Int J Cardiol
; 154(3): 362-5, 2012 Feb 09.
Article
in En
| MEDLINE
| ID: mdl-22133469
Subject(s)
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drugs, Chinese Herbal
/
Cardiovascular Diseases
/
Phytotherapy
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Int J Cardiol
Year:
2012
Document type:
Article
Country of publication:
Netherlands